James P. Zallie, President and CEO of Ingredion (NYSE:INGR), reported the sale of 9,958 shares of common stock in an open-market transaction on Feb. 18, 2026, according to a SEC Form 4 filing.
|
Metric |
Value |
|---|---|
|
Shares sold (direct) |
9,958 |
|
Transaction value |
$1.16 million |
|
Post-transaction shares (direct) |
33,010 |
|
Post-transaction value (direct ownership) |
$3.84 million |
Transaction value based on SEC Form 4 reported price ($116.55); post-transaction value based on Feb. 18, 2026 market close ($116.42).
-
What is the impact on Zallie’s direct ownership and broader insider exposure?
Zallie’s direct holdings were reduced from 42,968 to 33,010 shares, representing 0.0520% of the company’s outstanding shares as of the latest report, and he maintains no indirect or derivative positions reported in this filing. -
Is there any indication this transaction reflects a change in sentiment or is out of pattern?
The sale was executed pursuant to a pre-established Rule 10b5-1 plan and falls within the typical cadence and capacity-driven reduction observed in Zallie’s recent trading history.
|
Metric |
Value |
|---|---|
|
Revenue (TTM) |
$7.22B |
|
Net income (TTM) |
$729M |
|
Dividend yield |
2.79% |
|
1-year price change (as of Feb. 28, 2026) |
-10.04% |
Ingredion is a global ingredient solutions provider that produces and sells starches, sweeteners, corn oil, protein feeds, and specialty food ingredients derived from corn and other starch-based materials. It serves food and beverage manufacturers, animal nutrition producers, and industrial clients globally across North America, South America, Asia-Pacific, and EMEA regions.
In addition to serving as President and CEO, Zallie was appointed Chairman of the Board of Ingredion on Feb. 11, 2026. He was unanimously elected as Chair after former Chair Gregory Kenny announced his decision to step down.
This move and Zallie’s sale of shares shouldn’t concern investors. Board member reshuffling is common among businesses, and Zallie’s transaction was part of a Rule 10b5-1 trading plan, which allows insiders to plan the purchase or sale of shares in advance. Last week, 33k of his direct shares were sold as part of the plan.
What may be of concern to investors though is that the company had a rather lackluster Q4 earnings report for its fiscal year 2025.
While net income and earnings per share (EPS) grew year-over-year, revenue declined during that period. In addition, the company posted its third consecutive quarter of decline in net income and EPS after starting the fiscal year strongly. The company is still recovering from global impacts on its production, so that is something investors may want to monitor.
